HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pharmacological rescue of Ras signaling, GluA1-dependent synaptic plasticity, and learning deficits in a fragile X model.

Abstract
Fragile X syndrome, caused by the loss of Fmr1 gene function, is the most common form of inherited mental retardation, with no effective treatment. Using a tractable animal model, we investigated mechanisms of action of a few FDA-approved psychoactive drugs that modestly benefit the cognitive performance in fragile X patients. Here we report that compounds activating serotonin (5HT) subtype 2B receptors (5HT2B-Rs) or dopamine (DA) subtype 1-like receptors (D1-Rs) and/or those inhibiting 5HT2A-Rs or D2-Rs moderately enhance Ras-PI3K/PKB signaling input, GluA1-dependent synaptic plasticity, and learning in Fmr1 knockout mice. Unexpectedly, combinations of these 5HT and DA compounds at low doses synergistically stimulate Ras-PI3K/PKB signal transduction and GluA1-dependent synaptic plasticity and remarkably restore normal learning in Fmr1 knockout mice without causing anxiety-related side effects. These findings suggest that properly dosed and combined FDA-approved psychoactive drugs may effectively treat the cognitive impairment associated with fragile X syndrome.
AuthorsChae-Seok Lim, Elizabeth T Hoang, Kenneth E Viar, Ruth L Stornetta, Michael M Scott, J Julius Zhu
JournalGenes & development (Genes Dev) Vol. 28 Issue 3 Pg. 273-89 (Feb 01 2014) ISSN: 1549-5477 [Electronic] United States
PMID24493647 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Dopamine Agents
  • Fmr1 protein, mouse
  • Receptors, AMPA
  • Serotonin Agents
  • Fragile X Mental Retardation Protein
  • ras Proteins
  • glutamate receptor ionotropic, AMPA 1
Topics
  • Animals
  • Disease Models, Animal
  • Dopamine Agents (pharmacology, therapeutic use)
  • Dose-Response Relationship, Drug
  • Female
  • Fragile X Mental Retardation Protein (genetics, metabolism)
  • Fragile X Syndrome (drug therapy)
  • Learning (drug effects)
  • Male
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Receptors, AMPA (genetics, metabolism)
  • Serotonin Agents (pharmacology, therapeutic use)
  • Signal Transduction (drug effects)
  • Synapses (drug effects)
  • ras Proteins (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: